Novel Agents and Combination Regimens in Elderly Patients with CLL
There is a need for clinicians to evaluate available data from recent clinical trials and to incorporate new findings to the management of their older patient population, as appropriate.
This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Evaluate available data from recent clinical trials to incorporate new findings in CLL into the management of their older patient population
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
- 0.25 Participation
- 0.24 Nurse
- 0.25 Pharmacist
- 0.25 Physician